Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global Healthcare Conference
ALISO VIEJO, Calif., Feb. 14, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the RBC Capital Markets' 2013 Global Healthcare Conference.
- Location: Palace Hotel, New York, NY
- Presentation date: Tuesday February 26, 2013
- Presentation time: 4:35 p.m. ET
A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)
Avanir Investor & Media Contact
Ian Clements , PhD
ir@avanir.com
+1 (949) 389-6700
SOURCE Avanir Pharmaceuticals, Inc.
RELATED LINKS
https://www.avanir.com
More by this Source
AVANIR Pharmaceuticals To participate in two conferences in March
Mar 01, 2013, 09:00 ET
Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
Feb 07, 2013, 16:00 ET
Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
Feb 07, 2013, 08:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.